Irene Becklund will resign as Chief Accounting Officer and Principal Accounting Officer, effective October 9, 2026. Her resignation is not due to any disagreement with the company's accounting principles or financial statements. The company has entered into an advisory agreement with her to provide support until July 10, 2027. Hims & Hers Health, Inc. is a multi-channel telehealth platform providing access to personalized health and wellness solutions.

Hims & Hers Health, Inc. subsidiaries XeCare LLC and Apostrophe Pharmacy LLC entered into a $400,000,000 Master Receivables Purchase Agreement with JPMorgan Chase Bank, N.A. to sell eligible receivables for cash. The Company entered into Amendment No. 4 to its existing Revolving Credit and Guaranty Agreement to permit the transactions and add a new $400,000,000 indebtedness basket. Hims & Hers Health, Inc. is a telehealth and wellness company providing personalized health solutions.